Analysis of disease spectrum of corporate executives after physical examination

Abstract

Introduction: To find out the disease spectrum of corporate executives and screen the common chronic diseases.
Methods: The physical examination data of corporate executives were collected to carry out cross-sectional study.
Results: Among 231 subjects, there were one hundred and ninety four males, which made up 85.3%, and thirty seven females, which made up 14.7%. The detection rate of chronic diseases in corporate executive was high. Specifically, the incidence rate of blood viscosity rise was 87.8%; the incidence rate of blood lipid rise was 79.5%; the incidence rate of obesity and overweight was 76.7%; the infection rate of Helicobacter pylori was 55.7%; the prevalence rate of fatty liver was 52.1%; the prevalence rate of kidney stones was 43.5%; the incidence of abnormal pancreatic echo was 52.3%; the incidence rate of abnormal TCD was 66.2%; the detection rate of coarse gallbladder wall was 35.5%. The prevalence rate of bone mineral density reduction was 39.6%; the detection rate of reduction of diastolic function of left ventricle was 37.5%; the incidence rate of raised serum uric acid was 28.6%; the incidence rate of blood glucose going up was 22%; the incidence rate of liver cyst was 19.5%. The prevalence rate of blood LDL rise was 23.9%; the prevalence rate of abnormal thyroid was 21.3%; the incidence rate of arteriosclerosis was 17.5%; the prevalence rate of hypertension was 17.4%.
Conclusion: The corporate executives are high risk group of common metabolic diseases and cardiovascular and cerebrovascular diseases. Therefore, screening should be strengthened for them.